4//SEC Filing
Ocumension Therapeutics 4
Accession 0001840315-23-000007
CIK 0001314102other
Filed
Dec 6, 7:00 PM ET
Accepted
Dec 7, 9:21 PM ET
Size
7.4 KB
Accession
0001840315-23-000007
Insider Transaction Report
Form 4
Ocumension Therapeutics
10% Owner
Transactions
- Sale
common stock
2023-12-05$19.91/sh−733,758$14,609,122→ 2,276,963 total - Sale
common stock
2023-12-06$18.41/sh−266,242$4,901,515→ 2,010,721 total
Documents
Issuer
EyePoint Pharmaceuticals, Inc.
CIK 0001314102
Entity typeother
IncorporatedCayman Islands
Related Parties
1- filerCIK 0001840315
Filing Metadata
- Form type
- 4
- Filed
- Dec 6, 7:00 PM ET
- Accepted
- Dec 7, 9:21 PM ET
- Size
- 7.4 KB